Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

29.10 +0.08 (+0.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,256,436
Open 28.99
Bid (Size) 28.33 (1)
Ask (Size) 29.90 (1)
Prev. Close 29.02
Today's Range 29.00 - 29.23
52wk Range 21.75 - 33.71
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Alkermes Honors Women's Equality Day
Via ACCESSWIRE

Performance

YTD
+12.49%
+12.49%
1 Month
+6.91%
+6.91%
3 Month
-10.90%
-10.90%
6 Month
+7.74%
+7.74%
1 Year
+32.27%
+32.27%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Top Biotech Stocks Defying the Bear Market
Via The Motley Fool
Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega
Via Benzinga
Earnings Preview: Alkermes
Via Benzinga
Where Alkermes Stands With Analysts
Via Benzinga
Alkermes Earnings Perspective: Return On Capital Employed
Via Benzinga
Analyst Expectations for Alkermes's Future
Via Benzinga
Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor
From Sarissa Capital Management LP
Via Business Wire
Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders
From Sarissa Capital Management LP
Via Business Wire
Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board
From Sarissa Capital Management LP
Via Business Wire
Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board
From Sarissa Capital Management LP
Via Business Wire
The Latest Analyst Ratings for Alkermes
Via Benzinga
A Preview Of Alkermes's Earnings
Via Benzinga
Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board
From Sarissa Capital Management LP
Via Business Wire
Sarissa Urges Shareholders to Vote for Sarissa Nominees to Provide Much Needed Oversight and Accountability to Alkermes
From Sarissa Capital Management LP
Via Business Wire
Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board
From Sarissa Capital Management LP
Via Business Wire
Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements
Via Benzinga
Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders
From Sarissa Capital Management LP
Via Business Wire
Alkermes Stock Sees Rising Relative Strength Rating
Via Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
Alkermes: Commercialization Program On Track, Sales Coming In Strong
Via Talk Markets
Alkermes Stock Sees Rising Relative Price Strength
Via Investor's Business Daily
Seattle Genetics' 'Refreshing' Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.